nifedipine and iloprost

nifedipine has been researched along with iloprost in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19907 (28.00)18.7374
1990's8 (32.00)18.2507
2000's4 (16.00)29.6817
2010's5 (20.00)24.3611
2020's1 (4.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A1
Cooke, ED; Nicolaides, AN1
Boxer, LA; Ljungman, AG; Marks, RM; Morganroth, ML; Riva, CM; Schoeneich, SO; Todd, RF; Ward, PA1
Belcher, G; Watson, HR1
Belch, JJ; Forbes, CD; O'Dowd, A; Sturrock, RD1
Ioannou, P; Talesnik, J1
Müller, B; Schmidtke, M1
Müller, B; Schmidtke, M; Witt, W1
Tiegs, G; Wendel, A; Wolter, M1
Almond, NE; Beacham, JA; Cooke, ED; Kirby, JD; Mant, TG; Rademaker, M; Smith, RE1
Demĭrel, E; Türker, RK1
Barth, HL; Hempelmann, RG; Mehdorn, HM; Pradel, RH; Ziegler, A1
Gross, JS; Shua-Haim, JR1
Bazzi, S; Berruti, V; Castagnone, D; Mascagni, B; Quarto di Palo, F; Rivolta, R; Scorza, R1
Brennecke, SP; Coleman, HA; Davies, NK; Parkington, HC; Tonta, MA1
Ghofrani, HA; Grimminger, F; Olschewski, H; Schermuly, R; Seeger, W; Temmesfeld-Wollbruck, B; Walmrath, D1
Kaiukov, AV; Kokorin, KV; Konychev, AV; Koreshkina, TA1
Ewert, R; Felix, S; Opitz, C; Schlag, K; Wensel, R1
Kayikçioğlu, M; Kültürsay, H1
Girndt, M; Herink, AK; Keysser, G; Köthe, L1
Araújo, AC; Jorge, VC; Noronha, C; Panarra, A; Riso, N; Vaz Riscado, M1
Atay, S; Campochiaro, C; Clark, KEN; Denton, CP; Ong, V1
Abignano, G; Lettieri, G; Mennillo, GA1

Reviews

3 review(s) available for nifedipine and iloprost

ArticleYear
Raynaud's syndrome.
    BMJ (Clinical research ed.), 1990, Mar-03, Volume: 300, Issue:6724

    Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Epoprostenol; Female; Humans; Iloprost; Moxisylyte; Nifedipine; Raynaud Disease

1990
[Raynaud's phenomenon: clinical aspects of the disease].
    Vestnik khirurgii imeni I. I. Grekova, 2001, Volume: 160, Issue:2

    Topics: Calcium Channel Blockers; Cold Temperature; Diagnosis, Differential; Female; Humans; Iloprost; Male; Nifedipine; Plasmapheresis; Raynaud Disease; Risk Factors; Sensitivity and Specificity; Sex Factors; Vasodilator Agents

2001
[Current approach to the treatment of pulmonary arterial hypertension and our experience in the Cardiology Department of Medicine Faculty of Ege University].
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2009, Volume: 37, Issue:8

    Topics: Antihypertensive Agents; Diltiazem; Disease Progression; Epoprostenol; Humans; Hypertension, Pulmonary; Iloprost; Nifedipine; Turkey; Vasodilator Agents

2009

Trials

3 trial(s) available for nifedipine and iloprost

ArticleYear
Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
    BMJ (Clinical research ed.), 1989, Mar-04, Volume: 298, Issue:6673

    Topics: Administration, Oral; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Epoprostenol; Female; Hemodynamics; Humans; Iloprost; Infusions, Intravenous; Male; Nifedipine; Random Allocation; Raynaud Disease; Regional Blood Flow; Scleroderma, Systemic

1989
Effect of iloprost infusion on the resistance index of renal vessels of patients with systemic sclerosis.
    The Journal of rheumatology, 1997, Volume: 24, Issue:10

    Topics: Brachial Artery; Female; Humans; Iloprost; Kidney Cortex; Middle Aged; Nifedipine; Prospective Studies; Renal Circulation; Scleroderma, Systemic; Ultrasonography, Doppler, Color; Vascular Resistance

1997
Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
    American journal of respiratory and critical care medicine, 1999, Volume: 160, Issue:2

    Topics: Administration, Inhalation; Adult; Aged; Atrial Function, Right; Calcium Channel Blockers; Drug Therapy, Combination; Epoprostenol; Female; Heart Failure; Humans; Hypertension, Pulmonary; Iloprost; Infusions, Intravenous; Lung; Male; Middle Aged; Nifedipine; Nitric Oxide; Pulmonary Fibrosis; Pulmonary Gas Exchange; Pulmonary Wedge Pressure; Vascular Resistance; Vasodilator Agents; Ventilation-Perfusion Ratio; Vital Capacity

1999

Other Studies

19 other study(ies) available for nifedipine and iloprost

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bioorganic & medicinal chemistry letters, 2012, Dec-15, Volume: 22, Issue:24

    Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity

2012
Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers.
    American journal of respiratory cell and molecular biology, 1990, Volume: 3, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; Adenine; Adenylyl Cyclase Inhibitors; Animals; Cell Adhesion; Cyclic AMP; Iloprost; In Vitro Techniques; Macrophage-1 Antigen; Male; Neutrophils; Nifedipine; Permeability; Phosphodiesterase Inhibitors; Rats; Respiratory Distress Syndrome; Superoxides; Tetradecanoylphorbol Acetate

1990
Retrospective comparison of iloprost with other treatments for secondary Raynaud's phenomenon.
    Annals of the rheumatic diseases, 1991, Volume: 50, Issue:6

    Topics: Connective Tissue Diseases; Humans; Iloprost; Infusions, Intravenous; Nifedipine; Raynaud Disease; Retrospective Studies

1991
Platelet sensitivity to a prostacyclin analogue in systemic sclerosis.
    British journal of rheumatology, 1985, Volume: 24, Issue:4

    Topics: Adult; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Humans; Iloprost; Middle Aged; Nifedipine; Platelet Aggregation; Prostaglandins E, Synthetic; Prostaglandins, Synthetic; Raynaud Disease; Scleroderma, Systemic

1985
Platelet antiaggregatory substances inhibit arachidonic acid induced coronary constriction.
    Canadian journal of physiology and pharmacology, 1986, Volume: 64, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Arachidonic Acid; Arachidonic Acids; Cardiovascular Agents; Coronary Circulation; Dipyridamole; Epoprostenol; Guinea Pigs; Heart; Hydralazine; Iloprost; In Vitro Techniques; Male; Nifedipine; Perfusion; Platelet Aggregation; Rats; Rats, Inbred Strains; Vasoconstriction

1986
Microvascular effects of iloprost in the hamster cheek pouch.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1987, Volume: 17A

    Topics: Alprostadil; Animals; Capillary Permeability; Cheek; Cricetinae; Epoprostenol; Iloprost; Male; Mesocricetus; Microcirculation; Nifedipine; Vasodilation

1987
Action of the stable prostacyclin analogue iloprost on microvascular tone and -permeability in the hamster cheek pouch.
    Prostaglandins, leukotrienes, and medicine, 1987, Volume: 29, Issue:2-3

    Topics: Alprostadil; Animals; Blood Pressure; Capillary Permeability; Cricetinae; Dose-Response Relationship, Drug; Epoprostenol; Iloprost; Male; Mesocricetus; Microcirculation; Mouth Mucosa; Muscle Tonus; Nifedipine; Permeability; Platelet Aggregation; SRS-A

1987
Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.
    Biochemical pharmacology, 1989, Feb-15, Volume: 38, Issue:4

    Topics: Allopurinol; Animals; Chemical and Drug Induced Liver Injury; Eicosanoic Acids; Endotoxins; Epoprostenol; Galactosamine; Iloprost; Imidazoles; Male; Mice; Mice, Inbred Strains; Nifedipine; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Verapamil; Xanthine Oxidase

1989
Possible calcium channel modulating activity of iloprost in rabbit isolated vascular segments.
    General pharmacology, 1989, Volume: 20, Issue:6

    Topics: Animals; Calcium Channels; Epoprostenol; Female; Iloprost; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Potassium Chloride; Rabbits

1989
Effects of potassium channel openers in isolated human cerebral arteries.
    Neurosurgery, 1995, Volume: 37, Issue:6

    Topics: Benzopyrans; Calcium Channel Blockers; Carbachol; Cerebral Arteries; Cromakalim; Culture Techniques; Dose-Response Relationship, Drug; Endothelium, Vascular; Guanidines; Humans; Iloprost; Nifedipine; Nimodipine; Pinacidil; Potassium Channels; Pyrroles; Vasodilator Agents

1995
Geriatrics photo quiz. Raynaud's: classic "blue fingertips'.
    Geriatrics, 1996, Volume: 51, Issue:5

    Topics: Adult; Aged; Calcium Channel Blockers; Diagnosis, Differential; Female; Humans; Iloprost; Male; Middle Aged; Nifedipine; Raynaud Disease; Sympathectomy; Vasodilator Agents

1996
Hyperpolarization and slowing of the rate of contraction in human uterus in pregnancy by prostaglandins E2 and f2alpha: involvement of the Na+ pump.
    The Journal of physiology, 1999, Jan-01, Volume: 514 ( Pt 1)

    Topics: Albuterol; Calcium; Calcium Channel Blockers; Charybdotoxin; Cyclic AMP; Dinoprost; Dinoprostone; Enzyme Inhibitors; Female; Glyburide; Humans; Hypoglycemic Agents; Iloprost; Membrane Potentials; Myometrium; Nifedipine; Ouabain; Potassium; Potassium Channel Blockers; Potassium Channels; Pregnancy; Sodium-Potassium-Exchanging ATPase; Sympathomimetics; Tetraethylammonium; Uterine Contraction; Vasodilator Agents

1999
[Pulmonary hypertension in hereditary haemorrhagic teleangiectasia (Rendu-Osler-Weber disease). Progression over 10 years].
    Deutsche medizinische Wochenschrift (1946), 2005, Jun-10, Volume: 130, Issue:23

    Topics: Anticoagulants; Antihypertensive Agents; Bosentan; Calcium Channel Blockers; Diuretics; Endothelin Receptor Antagonists; Epistaxis; Epoprostenol; Female; Furosemide; Humans; Hypertension, Pulmonary; Iloprost; Middle Aged; Nifedipine; Pedigree; Phenprocoumon; Pyridines; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic; Treatment Failure; Vasodilator Agents

2005
[Treatment options of acral ulcers in MCTD].
    Medizinische Klinik (Munich, Germany : 1983), 2010, Volume: 105, Issue:11

    Topics: Adult; Amides; Analgesia, Patient-Controlled; Angiography, Digital Subtraction; Autonomic Nerve Block; Azathioprine; Combined Modality Therapy; Drug Therapy, Combination; Female; Fingers; Humans; Hyperbaric Oxygenation; Iloprost; Infusions, Intravenous; Mixed Connective Tissue Disease; Nifedipine; Prednisolone; Raynaud Disease; Ropivacaine; Skin Ulcer; Vasodilator Agents

2010
Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge.
    BMJ case reports, 2011, Sep-13, Volume: 2011

    Topics: Adult; Angiography; Aspirin; Atorvastatin; Calcium Channel Blockers; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iloprost; Male; Nifedipine; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrroles; Smoking Cessation; Thromboangiitis Obliterans

2011
Autoimmunity and immunodeficiency at the crossroad: autoimmune disorders as the presenting feature of selective IgM deficiency.
    BMJ case reports, 2019, Jan-03, Volume: 12, Issue:1

    Topics: Adult; Aftercare; Antirheumatic Agents; Autoimmune Diseases; Humans; Hydroxychloroquine; Iloprost; Immunoglobulin G; Immunoglobulin M; Immunologic Deficiency Syndromes; Infusions, Intravenous; Male; Mixed Connective Tissue Disease; Myalgia; Nifedipine; Synovitis; Treatment Outcome; Vasodilator Agents

2019
Foot ulcers in systemic sclerosis escape surgical amputation.
    Lancet (London, England), 2020, 09-12, Volume: 396, Issue:10253

    Topics: Aged; Analgesics, Opioid; Anti-Bacterial Agents; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Foot Ulcer; Humans; Iloprost; Naloxone; Nifedipine; Oxycodone; Rivaroxaban; Scleroderma, Systemic; Vasodilator Agents

2020